Slicing Through the Swamp of Over-Treatment: The Implications of South Korea's Auto Insurance '8-Week Rule'

According to a report by Maekyung, the full-scale implementation of the so-called '8-week rule,' which mandates strict screening for long-term treatment of car accident victims, is poised to bring sweeping changes to South Korea's auto insurance market and medical sector. Designed to curb moral hazard—where victims of minor accidents claim excessive insurance payouts through prolonged treatments—this reform ultimately aims to ease the premium burden on the general public.

1. The War on Moral Hazard: The Genesis of the '8-Week Rule'

For years, South Korea's auto insurance market has grappled with the chronic issue of 'nylon patients' (fake patients) and over-treatment by certain medical institutions. Minor fender-benders frequently resulted in months of unnecessary hospitalization or outpatient care at traditional Korean medicine clinics, driving up insurance payouts. This systemic inefficiency ultimately penalized honest policyholders through rising premium rates.

According to a report by Maekyung, financial authorities and regulators have officially implemented the '8-week rule' to root out these deeply embedded malpractices. Rather than arbitrarily cutting off care, this reform establishes a rigorous screening process for long-term treatments, signaling a decisive step toward restoring fiscal discipline in the insurance sector.

2. The Core Mechanism: How the '8-Week Rule' Operates

The crux of the '8-week rule' lies in shifting the burden of proof regarding the necessity of continued medical treatment onto the patients and their healthcare providers. Previously, insurers had limited leverage to challenge prolonged treatments demanded by accident victims.

Shifting the Burden of Proof to Medical Necessity

Under the newly established framework, if an accident victim requires treatment exceeding eight weeks, they must submit an official medical certificate containing a detailed clinical diagnosis. These claims will undergo strict evaluation by professional review bodies, such as the Health Insurance Review and Assessment Service (HIRA). If the medical necessity is not objectively justified, insurance coverage for subsequent treatments may be denied.

3. Ripple Effects Across the Insurance and Medical Sectors

The full-scale rollout of this rule is expected to trigger significant structural shifts across both the financial and healthcare landscapes.

• Improvement in Insurers' Loss Ratios: A sharp decline in unnecessary long-term outpatient visits and inflated medical bills will stabilize loss ratios, bolstering the underwriting profitability of major non-life insurers.


• Benefits for General Consumers: By plugging the leaks caused by moral hazard, the reform paves the way for potential premium reductions or at least stabilizes future rate hikes for the general public.


• Impact on the Medical Industry: Local clinics and traditional Korean medicine hospitals, which have historically relied heavily on traffic accident patients, are likely to experience a contraction in revenue, prompting a shift toward more standardized and evidence-based treatment protocols.

4. Conclusion: Navigating a Reconstructed Insurance Landscape

The implementation of the '8-week rule' is more than just a regulatory update; it is a vital milestone toward normalizing South Korea's auto insurance ecosystem and reducing unnecessary social costs. While initial friction from patients and certain medical sectors is inevitable, the long-term transition toward a transparent and rational healthcare utilization culture is highly positive. Investors and market participants should closely monitor how these regulatory tailwinds translate into improved fundamentals for the insurance sector.

To establish a clear investment direction amid complex market conditions, we recommend comprehensively leveraging FireMarkets' in-depth analysis content and fundamental on-chain data.